Business
Psychedelic biotech Psylo raises first funds – The Australian Financial Review
Startmate company Psylo is the latest company to attract funding for its pre-clinical psychedelic research.
The space is also attracting big investment dollars in the US, UK and Europe, with Beckley Psytech raising $US80 million in August, Atai Life Sciences raising $225 million for a NASDAQ listing in 2020 and new Chicago-based venture capital group Palo Santo…
Continue Reading
-
Noosa News22 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General15 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News15 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
Noosa News7 hours agoNew playground equipment encourages children to learn through ‘risky play’